- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01183260
Evaluation of the Trabecular Metal™ Revision Hip Cup Using Bone Mineral Density (DEXA)
Evaluation of the Trabecular Metal™ Acetabular Revision Cup Using Dual-Energy X-ray Absorptiometry (DEXA)
In 1997, the FDA approved the use of Trabecular Metal™ (Zimmer, Trabecular Metal Technology, Inc., Parsippany, NJ) for acetabular cups, a porous tantalum structural biomaterial that was developed to address the limitations of other implant materials, with the potential to improve implant fixation.
Porous tantalum (80% porosity) offers potentially greater ingrowth and bone graft incorporation, believed to be restricted by the low porosity of other commonly used implants (30%). Additionally, the low modulus of elasticity property (3 MPa) of porous tantalum provides more normal physiological loading conditions which theoretically reduce stress shielding and resultant bone loss surrounding the implant. These properties are much desired advantages for implants used in cementless THA.
Various porous tantalum implants have shown favorable clinical results. Unger et al. reported excellent bone graft incorporation of the acetabular component based on serial radiograph data at a minimum 1-year follow-up.
Dual-energy X-ray absorptiometry (DEXA) is a well-established method for detecting periprosthetic bone mass changes around the femoral and acetabular THA components.
The primary objective of this study is to quantify and compare periprosthetic bone mineral density (BMD) changes in THA revision patients receiving Trabecular Metal™ and metal-backed acetabular components, measured using DEXA scanning techniques. Additionally, this study will analyze and compare clinical outcomes of these patients, based on SF-12v2 and HOOS.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ohio
-
Cleveland, Ohio, United States, 44195
- The Cleveland Clinic
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age: 18 - 85 years
- Sex: Both male and female will be included. The male-to-female ratio will depend upon the patient population.
- Stable Health: At the time of surgery based on physical examination and medical history.
- Patient is a revision total hip recipient, which requires a metal-backed hemispherical cup.
- Patient or patient's legal representative has signed the Informed Consent form. The patient is capable of making informed decisions regarding his/her healthcare.
Exclusion Criteria:
- Patients undergoing bilateral surgery or had prior hip arthroplasty on contralateral side less than 6 months from date of surgery.
- Patients who do not plan to return to a Cleveland Clinic surgeon for follow-up visits (i.e. out of state/country patients who may choose to follow-up with a different surgeon).
- Patients with history of radiation therapy.
- Patients with known diagnosis of Brooker grade 3 or 4 HO (heterotopic ossification) in the hip joint region.
- Patients with known diagnosis of renal disease.
- Patients with known diagnosis of osteoporosis.
- Patients with history of steroid use in the hip joint region.
- Patients that have had a previous lumbar fusion.
- Patients whose surgical reconstruction required a pelvic cage or plate.
- Patient was a poor compliance risk - treated for ethanol or drug abuse, physical or mental handicap, etc.
- Any female of childbearing potential who is pregnant or is planning on becoming pregnant during the study period (~2 years postoperative).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Trabecular Metal Revision Cup
Patients randomized to this arm will receive a trabecular metal revision component which does not have a titanium inner surface and requires a cemented highly crosslinked polyethylene liner.
|
Revision of the acetabular cup
|
Active Comparator: Trabecular Metal Modular Cup
Patients randomized to this arm will receive a trabecular metal modular component which has a titanium inner surface and requires a non-cemented highly crosslinked polyethylene liner.
|
Revision of the acetabular cup
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Periprosthetic Bone Mineral Density (BMD) of Hip
Time Frame: 2 years postoperative; measured at 3 months (baseline), 6 months, 1 year, 2 year postoperative
|
Quantify and compare periprosthetic bone mineral density (BMD) changes in THA revision patients receiving Trabecular Metal™ and metal-backed acetabular components, measured using DEXA scanning techniques.
Region 1 forms the superior-lateral region, Region 2 forms the superior-medial region, and Region 3 forms the inferior-medial region around the acetabular component.
For each region, the mean change in BMD was calculated using the following equation described by Wilkinson et al (J Bone Joint Surg Br., 2001): mean percent change in BMD = (BMD1-BMD2) x 2 x 100 / (BMD1 + BMD2).
These regions were patient specific and remained the same each time the patient was scanned.
|
2 years postoperative; measured at 3 months (baseline), 6 months, 1 year, 2 year postoperative
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Functional and General Health Outcome Assessments
Time Frame: 2 years postoperative; measured preoperatively and 3 months, 6 months, 1 year, 2 year postoperative
|
Analyze and compare functional and general health outcomes of these patients, based on Hip disability and Osteoarthritis Outcomes Score (HOOS) and 12-item Short Form Health Survey (SF-12v2). All subscale scores are calculated independently and range from 0 to 100, where 100 indicates no problems:
|
2 years postoperative; measured preoperatively and 3 months, 6 months, 1 year, 2 year postoperative
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- ZIMM1007WB
- 09-859 (Other Identifier: CCF IRB)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Revision, Joint
-
Hadassah Medical OrganizationUnknown
-
Smith & Nephew, Inc.RecruitingAdvanced Degeneration of the Hip Joint | Revision of the Hip JointUnited States, Canada, Australia, Hong Kong, India
-
Zimmer BiometWithdrawnOsteoarthritis | Revision Arthroplasty
-
Mentor Worldwide, LLCActive, not recruitingPrimary Breast Augmentation | Primary Breast Reconstruction | Revision Breast Augmentation | Revision Breast ReconstructionUnited States
-
Charite University, Berlin, GermanyAesculap AGUnknownRevision Total Knee Arthroplasty Because of | Loosening | Instability | Impingement | or Other Reasons Accepted as Indications for TKA Exchange. | The Focus is to Determine the Precision of Joint Line Restoration in Navigated vs. Conventional Revision Total Knee ArthroplastyGermany
-
DePuy OrthopaedicsTerminatedOsteoarthritis | Degenerative Arthritis | Revision ArthroplastyCanada
-
Frederiksberg University HospitalUnknownHip RevisionDenmark
-
University of AarhusOdense University Hospital; Aarhus University Hospital; Vejle Hospital; Gødstrup... and other collaboratorsRecruitingRevision Total Hip ArthroplastyDenmark
-
Michael DunbarCompletedRevision Total Knee ReplacementCanada
-
Medacta USARecruiting
Clinical Trials on Trabecular Metal Revision Cup
-
Sahlgrenska University Hospital, SwedenCompletedProsthesis LooseningSweden
-
Orthopaedic Innovation CentreActive, not recruiting
-
Rigshospitalet, DenmarkZimmer BiometActive, not recruiting
-
Dalhousie UniversityZimmer BiometCompleted
-
Washington Hospital Healthcare SystemZimmer BiometRecruiting
-
Nova Scotia Health AuthorityZimmer BiometCompletedSpinal Stenosis | Spondylolisthesis | Degenerative Lumbar Disc DiseaseCanada
-
Dalhousie UniversityStryker Trauma GmbHCompletedOsteoarthritis
-
Stryker Trauma GmbHCompletedFemur Head Necrosis | Primary Osteoarthritis | Congenital Dislocations | Femur Neck Fracture | Post-traumatic Osteoarthritis of Hip Nos